Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Lowfloatmining1on Dec 08, 2020 9:47pm
293 Views
Post# 32064578

Target $

Target $

Current market cap is undervalued with recent  developments and Health Canada approval. Factoring in the current outstanding shares and what a fair market valuation should be my price target is $4.50 

This is IMO a multi day runner with substantial upside. These tests having the ability to provide results within 15 minutes is truly remarkable. 

I see these being implemented at air ports globally and large scale work environments. 

Missed the boat today but will be starting a position tomorrow after doing my own dd.  

My only advise to those is don't listen to the bashers here. At .16 I called a close of .24 just by the lvl2 action. Large buy orders and a strong close. Wish I took my own advice but there is always tomorrow. 

This test is not only a great achievement by the company but a much needed one in the current state we are living. 

Congratulations and don't sell yourself short this is far from done. 

GL

<< Previous
Bullboard Posts
Next >>